Meibography

Meibography is the imaging of the meibomian glands, the oil-producing glands set within the eyelids whose secretion forms the protective lipid layer of the tear film. Using infrared imaging, it reveals the structure of the glands, showing whether they are healthy, distorted, shortened or lost. It is one of the most informative and most persuasive tools in dry eye care.

Why it matters

Meibomian gland dysfunction is the leading cause of evaporative dry eye, yet gland damage can progress silently before symptoms become severe. Meibography makes that damage visible, allowing the clinician to gauge how much gland tissue remains and to track change over time. It directly informs the eyelid-anomaly driver group in the TFOS DEWS III subclassification (TFOS DEWS III, 2025, American Journal of Ophthalmology).

How it fits the workup

Meibography sits within the ordered dry eye workup, complementing lid expression, which assesses how the glands function, with a picture of their structure. Together they build a fuller account of the lid's contribution to the patient's disease, which is essential for choosing treatment.

A tool for engagement

Beyond its diagnostic value, meibography is one of the most effective ways to engage patients in their own care. Seeing the actual state of their glands often motivates people to commit to treatment in a way that verbal explanation alone does not. Espansione's me-check® platform captures meibography as part of its consolidated screening, feeding a consistent record that supports the diagnose-then-treat pathway.

Not all solutions and indications are cleared in all countries and for all cohorts. Every piece of information ought to be considered as fact-based evidence deriving from publicly available literature, for the sole purpose of scientific exchange.